- Open
- 48.50
- High
- 49.00
- Low
- 48.99
- Close
- 49.00
- Change
- -0.50 (-1.03%)
- Volume
- 2,533
⌘K
| 22 May 2026 | 12:38:58 | Posting of Annual Report and Notice of AGM |
| 21 May 2026 | 07:00:09 | AMR Bio: Commercial Update |
| 19 May 2026 | 07:01:01 | Final Results for the year ended 31 December 2025 |
| 19 May 2026 | 07:00:04 | Phantom Carried Interest Scheme |
| 12 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 27 Jun 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 8 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
| 22 May 2026 | 12:38:58 | Posting of Annual Report and Notice of AGM |
| 21 May 2026 | 07:00:09 | AMR Bio: Commercial Update |
| 19 May 2026 | 07:01:01 | Final Results for the year ended 31 December 2025 |
| 19 May 2026 | 07:00:04 | Phantom Carried Interest Scheme |
| 12 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 27 Jun 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 8 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
| 14 May 2026 | 07:00:07 | Notice of Final Results |
| 28 May 2026 |
| EMV Capital advances XF-73 toward late-stage trials for surgical infection prevention |
| 21 May 2026 | IXICO, Ilika, EMV Capital, Zephyr Energy, Metals One, Bradda Head Lithium - Small Cap Snapshot |
| 21 May 2026 | EMV Capital's AMR Bio advances infection-prevention drug towards phase III trial |
| 19 May 2026 | Thor Explorations, IXICO, EMV Capital, Empire Metals, Coiled Therapeutics - Small Cap Snapshot |
| 19 May 2026 | Thor Explorations, IXICO, EMV Capital, Empire Metals, Coiled Therapeutics - Small Cap Snapshot |
| 19 May 2026 | EMV Capital grows assets under management to £112.5m as venture platform scales |
| 14 May 2026 | 07:00:07 | Notice of Final Results |
| 28 May 2026 |
| EMV Capital advances XF-73 toward late-stage trials for surgical infection prevention |
| 21 May 2026 | IXICO, Ilika, EMV Capital, Zephyr Energy, Metals One, Bradda Head Lithium - Small Cap Snapshot |
| 21 May 2026 | EMV Capital's AMR Bio advances infection-prevention drug towards phase III trial |
| 19 May 2026 | Thor Explorations, IXICO, EMV Capital, Empire Metals, Coiled Therapeutics - Small Cap Snapshot |
| 19 May 2026 | Thor Explorations, IXICO, EMV Capital, Empire Metals, Coiled Therapeutics - Small Cap Snapshot |
| 19 May 2026 | EMV Capital grows assets under management to £112.5m as venture platform scales |